For a lot of people the idea of treating cancer or to stop the aging process seems like something just past impossible. However to someone like Mikhail Blagosklonny it is part of his lifes work to study and research both of these issues and to find an answers. Dr. Blagosklonny is the professor of Oncology at Buffalo, New York’s Rosewell Cancer Institute. He has written, studied, and published many articles on cancer and the subject of aging. View Mikhail’s profile on Google Scholar.
During his research Dr. Mikhail Blagosklonny has reported the effects of a drug called Rapaymycin. The drug Rapaymycin is the drug given to patients after receiving an organ transplant. This drug is known to help the body from rejecting the organ while not being as toxic to the kidneys as previous anti-rejection drugs. However, in his studies Dr. Blagosklonny has seen that Rapaymycin is more than just a drug for organ rejection. He is studying this drug in many other medical conditions.
There has been work with Rapaymycin that has helped with a lung disease called Lymphangioleiomyomatosis (LAM), removal of facial angiofibromas, and a coronary stent coating. Rapaymycin is also known as Sirolimus within the medical community and this is being used to help treat cancer. Doctors are seeing that Rapaymycin is helping the body fight tumors and for transplant patients who take the drug for anti-rejection a lower incidence of cancer is occuring.
Dr. Mikhail Blagosklonny sees the future in curing cancer and saving patients from the pain and cost of this awful disease. His research and life’s work in the field of cancer research and aging will continue to inspire and motivate a cure. Dr. Blagosklonny is taking his research in a way of developing a way to save a patients healthy cells while trying to kill off the bad cells. The future holds much hope and hard work that he is not afraid of. He also sees that cancer treatments are currently some of the most costly and for some patients impossible. This is something that Dr. Blagosklonny sees changing in the future. He wants research and study to find a way that this disease can be eradicated for every person no matter their social standing.
With Dr. Blagosklonny’s work on cancer, aging, and the uses of Rapaymycin it seems as if there is light at the end of the tunnel. Unafraid of hard work and a definite explorer of roads not travelled Dr. Blagosklonny will continue his search and teachings for a better quality of life. Read more about Mikhail on Crunchbase.